On the contrary, no statistically significant differences were found with reference to the incidence of infections and antibiotic therapy between the intervention group and controls (infections were 25% in the intervention group vs. 44% in the placebo; anthibiotic therapy 12% vs. 37%; p > 0.05), and the modulation of CRP in the intervention group did not differ significantly from that recorded by the control group. The gene discussed is CRP; the disease is infection.